2021
DOI: 10.3389/fneur.2020.563037
|View full text |Cite
|
Sign up to set email alerts
|

Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report

Abstract: This study reported two cases of intracranial thrombotic events of aplastic anemia (AA) under therapy with cyclosporine-A (CsA) and reviewed both drug-induced cerebral venous thrombosis (CVT) and CsA-related thrombotic events systematically. We searched PubMed Central (PMC) and EMBASE up to Sep 2019 for publications on drug-induced CVT and Cs-A-induced thrombotic events. Medical subject headings and Emtree headings were used with the following keywords: “cyclosporine-A” and “cerebral venous thrombosis OR cereb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 111 publications
(10 reference statements)
0
5
0
Order By: Relevance
“…All CVT patients who fulfilled the screening criteria were included in the final analysis, whether or not with clear etiologies. Referring to literatures about the CVT etiologies, 2 , 12 , 13 , 14 well‐established risk factors of CVT in this study mainly covered with overweight (body mass index, BMI > 25.0 kg/m 2 ), obstetric causes (pregnancy or postpartum), oral contraceptive use, hemopathy (i.e., anemia, thrombocythemia or polycythemia vera), protein C/S deficiency, nephrotic syndrome, connective tissue disease (i.e., antiphospholipid syndrome, APS and systemic lupus erythematosus, SLE), hyperhomocysteinemia (>20.0 mmol/L), and infection (i.e., mastoiditis, periodontal abscess, etc.) as well as other causes (such as diarrhea, therapy with cyclosporine A, malignancy, ovarian hyperstimulation syndrome, hormonal therapy, etc.).…”
Section: Methodsmentioning
confidence: 99%
“…All CVT patients who fulfilled the screening criteria were included in the final analysis, whether or not with clear etiologies. Referring to literatures about the CVT etiologies, 2 , 12 , 13 , 14 well‐established risk factors of CVT in this study mainly covered with overweight (body mass index, BMI > 25.0 kg/m 2 ), obstetric causes (pregnancy or postpartum), oral contraceptive use, hemopathy (i.e., anemia, thrombocythemia or polycythemia vera), protein C/S deficiency, nephrotic syndrome, connective tissue disease (i.e., antiphospholipid syndrome, APS and systemic lupus erythematosus, SLE), hyperhomocysteinemia (>20.0 mmol/L), and infection (i.e., mastoiditis, periodontal abscess, etc.) as well as other causes (such as diarrhea, therapy with cyclosporine A, malignancy, ovarian hyperstimulation syndrome, hormonal therapy, etc.).…”
Section: Methodsmentioning
confidence: 99%
“…3,4 Alternative reports have linked renal transplant and subsequent immunosuppression to hypercoagulability, although this is more notably associated with therapies that are not relevant to this example. 4,5 Finally, premorbid atherosclerotic disease may have contributed to this patient's atypical presentation. Multiple complex comorbid conditions contributing to cerebral vascular risk further highlight the importance of aggressive, multidisciplinary management in this case.…”
Section: Discussionmentioning
confidence: 95%
“…Treatment with cyclosporin and corticoids increased the risk of venous thromboembolism, although not specifically for CVST [9][10][11]. The mechanism of cyclosporin thrombogenicity is still controversial.…”
Section: Discussionmentioning
confidence: 99%
“…Cyclosporin also induces endothelial cell dysfunction by suppressing nitric oxide production and initiating the coagulation pathway. Increased D-dimer and fibrinogen level was also associated with cyclosporin [11]. The time range in which cyclosporin could induce CVST is between 9 days to 11 months, and a specific time for this induction remains unclear [10].…”
Section: Discussionmentioning
confidence: 99%